Clement Leong
Fondateur chez Ascend Biopharmaceuticals Ltd.
Profil
Clement Leong is the founder of Ascend Biopharmaceuticals Ltd.
(founded in 2003) where he holds the title of Chief Executive Officer, Director & MD.
He is currently the Executive Chairman at Avipep Pty Ltd.
Dr. Leong has also held positions as Chairman at 4G Vaccines Pty Ltd., Director at SciVentures Investments Pty Ltd., Director at Medsaic Pty Ltd., and Director at Glutagen Pty Ltd.
In terms of education, Dr. Leong holds a doctorate degree from The University of Western Australia and an MBA from the Australian Graduate School of Management.
Postes actifs de Clement Leong
| Sociétés | Poste | Début |
|---|---|---|
Avipep Pty Ltd.
 Avipep Pty Ltd. Medical SpecialtiesHealth Technology Avipep Pty Ltd. commercializes protein biopharmaceuticals and in-vivo diagnostic products. It focuses on developing Avibodies as a platform for targeting cells in the body with a focus on antibody-drug conjugates (ADC) for the treatment of cancer. The company was founded on April 7, 2005 and is headquartered in Parkville, Australia. | Président | 17/05/2010 |
Ascend Biopharmaceuticals Ltd.
 Ascend Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia. | Fondateur | 10/09/2003 |
Anciens postes connus de Clement Leong
| Sociétés | Poste | Fin |
|---|---|---|
SciVentures Investments Pty Ltd.
 SciVentures Investments Pty Ltd. Investment ManagersFinance SciVentures Investments Pty Ltd (SciVentures Investments) is a venture capital subsidiary of Government of Australia founded in 2002 by Gregory R. Smith, Ross Chessari and David James. The firm is headquartered in Victoria, Australia. | Director of Investments | 30/11/2012 |
4G Vaccines Pty Ltd.
 4G Vaccines Pty Ltd. Pharmaceuticals: OtherHealth Technology 4G Vaccines Pty Ltd. commercializes vaccine technologies. The firm provides immunotherapeutic treatment for breast cancer focused on two key innovations-use of mimic peptides and a potent cell-mediated stimulating adjuvant with potential use in other cancers. The company is headquartered in Heidelberg, Australia. | Président | - |
Glutagen Pty Ltd.
 Glutagen Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Glutagen Pty Ltd. develops enzyme therapies for the treatment of gluten intolerance and coeliac disease. The company has two products Glutazyme and Glutaren. The company was founded by Teodor Stelmasiak in 2001 and is headquartered in South Melbourne, Australia. | Directeur/Membre du Conseil | - |
Medsaic Pty Ltd.
 Medsaic Pty Ltd. Pharmaceuticals: MajorHealth Technology Medsaic Pty Ltd. commercializes a platform technology based on a protein microarray for the diagnosis of disease through the identification of patterns of antigen expression on cells. The company was founded in 2000 and is headquartered in Victoria, Australia. | Directeur/Membre du Conseil | - |
Formation de Clement Leong
| The University of Western Australia | Doctorate Degree |
| Australian Graduate School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
SciVentures Investments Pty Ltd.
SciVentures Investments Pty Ltd. Investment ManagersFinance SciVentures Investments Pty Ltd (SciVentures Investments) is a venture capital subsidiary of Government of Australia founded in 2002 by Gregory R. Smith, Ross Chessari and David James. The firm is headquartered in Victoria, Australia. | Finance |
Avipep Pty Ltd.
Avipep Pty Ltd. Medical SpecialtiesHealth Technology Avipep Pty Ltd. commercializes protein biopharmaceuticals and in-vivo diagnostic products. It focuses on developing Avibodies as a platform for targeting cells in the body with a focus on antibody-drug conjugates (ADC) for the treatment of cancer. The company was founded on April 7, 2005 and is headquartered in Parkville, Australia. | Health Technology |
Medsaic Pty Ltd.
Medsaic Pty Ltd. Pharmaceuticals: MajorHealth Technology Medsaic Pty Ltd. commercializes a platform technology based on a protein microarray for the diagnosis of disease through the identification of patterns of antigen expression on cells. The company was founded in 2000 and is headquartered in Victoria, Australia. | Health Technology |
Glutagen Pty Ltd.
Glutagen Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Glutagen Pty Ltd. develops enzyme therapies for the treatment of gluten intolerance and coeliac disease. The company has two products Glutazyme and Glutaren. The company was founded by Teodor Stelmasiak in 2001 and is headquartered in South Melbourne, Australia. | Commercial Services |
4G Vaccines Pty Ltd.
4G Vaccines Pty Ltd. Pharmaceuticals: OtherHealth Technology 4G Vaccines Pty Ltd. commercializes vaccine technologies. The firm provides immunotherapeutic treatment for breast cancer focused on two key innovations-use of mimic peptides and a potent cell-mediated stimulating adjuvant with potential use in other cancers. The company is headquartered in Heidelberg, Australia. | Health Technology |
Ascend Biopharmaceuticals Ltd.
Ascend Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia. | Health Technology |